glp 1 and alcohol glp-1 reduction receptor agonists show promise in treating substance use disorders GLP-1 reduces heavy drinking days – Effects of glucagon‐like peptide 1

These findings underscore the crucial role of glucose transport and metabolism in dopaminergic cell death and the development of PD

Engaging in community activities or support groups (including ones online) can be beneficial for feeling less isolated and anxious

A subsequent 12-week human clinical trial demonstrated the systems transformative efficacy

Healthcare Systems: As demand for GLP-1RAs grows, governments and healthcare systems will need to consider whether to reimburse new weight-loss drugs and at what cost

general population consumers over age 21 with an oversample to n=150 of those who are or have taken GLP-1s for weight loss

Endocrinology (2001) 142(10):424450